Abcl stock forecast.

Analyst projections state that ABCL is forecast to be at a low of $10.00 and a high of $34.00. In order for the stock price to hit the forecast high, the stock would need to plunge -660.63% from its current level, while the stock would need to crash -123.71% from its current level to reach the projected low.It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...13 sept 2023 ... ABCL stock has a median price target of 28.00, with a high estimate of 34.00 and a low estimate of 12.00, indicating potential for substantial ...See the latest AbCellera Biologics Inc Ordinary Shares stock price (ABCL:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Nov 2, 2023 · AbCellera Biologics Inc. reported earnings of -$ 0.10 per ABCL share on Nov 2, 2023. AbCellera Biologics Inc. fell short of analysts' expectations by -28.57%. Meanwhile, the company posted an EPS of -$ 0.12 last year, which is a -193.33% lower compared to the same period last year. Report Date. Nov 2, 2023. Track AbCellera Biologics Inc (ABCL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Analyst projections state that ABCL is forecast to be at a low of $10.00 and a high of $34.00. In order for the stock price to hit the forecast high, the stock would need to plunge -660.63% from its current level, while the stock would need to crash -123.71% from its current level to reach the projected low.VIE : 53.01 (unch) AbCellera Biologics (ABCL) Q2 2023 Earnings Call Transcript Motley Fool - Fri Aug 4, 12:00AM CDT. ABCL earnings call for the period ending June 30, 2023. ABCL : 4.18 (-5.00%) AbCellera Biologics (ABCL) Q1 2023 Earnings Call Transcript Motley Fool - Thu May 4, 11:30PM CDT.

ABCL | Complete AbCellera Biologics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. 4 ago 2023 ... As of Friday, August 04, AbCellera Biologics Inc's ABCL share price has dipped by 13.34%, which has investors questioning if this is right ...Abcellera Biologics Inc (ABCL) Company Description. AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various …ABCL - Cup & Handle Breakout Trade Abcellera Biologics is a biotech stock setting up in a textbook cup with handle pattern. The stock has growing institutional sponsorship as shown in the chart from MarketSmith on the chart. It also has a relative strength ranking of 97/100. Shares formed a cup with a 37% depth and have since driftAbcellera ...Dec 24, 2020 · About the AbCellera Biologics Inc stock forecast. As of 2023 November 28, Tuesday current price of ABCL stock is 4.530$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).

An XYZ stock analysis is the complement to an ABC analysis, and adds a layer of statistical review that shows the standard deviation of usage. ... Based on these classifications, companies can use the demand forecast and XYZ material classification to determine optimal order schedules.

Find the latest AbCellera Biologics Inc. ABCL analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating.

Insiders purchased significant amount of AbCellera stock directly after Q1. See why I ABCL shares are increasingly attractive for long-term, patient investors.Jan 5, 2023 · A $14.3 billion market cap divided by 330 million shares outstanding equals a valuation of $43.33 per share. Discounting a year 2030, $43.33 valuation, using a 10% discount rate gives us a present ... Nov 27, 2023 · AbCellera Biologics (ABCL) is a biotech company that discovers antibodies from natural immune responses. The company has a consensus rating of Buy and a forecasted upside of 461.1% from its current price of $4.04. See the latest news, analysis, earnings, and insider trading of ABCL stock on MarketBeat. Complete AbCellera Biologics Inc. stock information by Barron's. View real-time ABCL stock price and news, along with industry-best analysis.ABCL Stock Forecast - Is ABCL a buy or sell? Find out now with a free analysis on AbCellera Biologics. Should I buy or sell ABCL? ABCL Stock Analysis - [Full Report] ABCL Chart by TradingView. Antibodies Stocks Antibody Stocks Biologics Stocks Database Stocks Drug Stocks Immune Stocks Natural Stocks2 days ago · Stock Price Forecast. According to 7 stock analysts, the average 12-month stock price forecast for ABCL stock stock is $23.29, which predicts an increase of 436.64%. The lowest target is $12 and the highest is $32. On average, analysts rate ABCL stock stock as a strong buy.

Future criteria checks 2/6. AbCellera Biologics's earnings are forecast to decline at 12.1% per annum while its annual revenue is expected to grow at 23.9% per …Analyst projections state that ABCL is forecast to be at a low of $10.00 and a high of $34.00. In order for the stock price to hit the forecast high, the stock would need to plunge -660.63% from its current level, while the stock would need to crash -123.71% from its current level to reach the projected low.ABCL stock recorded 16/30 (53%) green days with 5.07% price volatility over the last 30 days. Based on our AbCellera Biologics stock forecast, it's now a bad time to buy ABCL stock because it's trading 6.53% above our forecast. Disclaimer: This is not investment advice. The information provided is for general information purposes only. Nov 29, 2023 · It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ... ABCL. The Nasdaq Stock Market. Indicate by check mark whether the registrant (1) ... The market price of our common stock could decline if one or more of these ...Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...At the close of trading, the stock’s price was $4.50, to imply an increase of 1.58% or $0.07 in intraday trading. The ABCL share’s 52-week high remains $14.15, putting it -214.44% down since that peak but still an impressive 14.0% since price per share fell to its 52-week low of $3.87.

1 Month Ago. -$0.12. 3 Months Ago. -$0.14. AbCellera Biologics Inc. analyst estimates, including ABCL earnings per share estimates and analyst recommendations. Find the latest AbCellera Biologics Inc. ABCL analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating.

Based on 3 Wall Street analysts offering 12 month price targets for Workhorse Group in the last 3 months. The average price target is $2.83 with a high forecast of $4.00 and a low forecast of $1.50. The average price target represents a 626.01% change from the last price of $0.39. Highest Price Target $4.00. Average Price Target $2.83.James O'Neil/DigitalVision via Getty Images. AbCellera Biologics ( NASDAQ: ABCL) to date has been quite a lousy investment. From the IPO high of $58.90, all the way down to the current price of ...See the latest AbCellera Biologics Inc Ordinary Shares stock price (ABCL:XNAS), related news, valuation, dividends and more to help you make your investing decisions.What this means: InvestorsObserver gives AbCellera Biologics Inc (ABCL) an overall rank of 36, which is below average. AbCellera Biologics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 36 means that 64% of stocks appear more favorable to our system.According to . 3 Wall Street analysts that have issued a 1 year ABCL price target, the average ABCL price target is $18.67, with the highest ABCL stock price forecast at $24.00 and the lowest ABCL stock price forecast at $12.00. Jun 6, 2022 · Insiders purchased significant amount of AbCellera stock directly after Q1. See why I ABCL shares are increasingly attractive for long-term, patient investors. 5 abr 2023 ... Their average price target stands at $19, implying 266% upside potential. AbCellera Biologics (ABCL). Pipette adding fluid to one of several ...Analyst projections state that ABCL is forecast to be at a low of $10.00 and a high of $34.00. In order for the stock price to hit the forecast high, the stock would need to plunge -660.63% from its current level, while the stock would need to crash -123.71% from its current level to reach the projected low.ABCL | AI Stock Analysis for AbCellera Biologics Inc ABCL Including Stock Price, Stock Chart, Technical, Fundamental, Sentiment Analysis and More. Start now …Real time AbCellera Biologics (ABCL) stock price quote, stock graph, news & analysis.

ABCL - Cup & Handle Breakout Trade Abcellera Biologics is a biotech stock setting up in a textbook cup with handle pattern. The stock has growing institutional sponsorship as shown in the chart from MarketSmith on the chart. It also has a relative strength ranking of 97/100. Shares formed a cup with a 37% depth and have since driftAbcellera ...

May 4, 2023 at 2:15 PM · 3 min read. AbCellera Biologics Inc. (ABCL) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to ...

ABCL - Cup & Handle Breakout Trade Abcellera Biologics is a biotech stock setting up in a textbook cup with handle pattern. The stock has growing institutional sponsorship as shown in the chart from MarketSmith on the chart. It also has a relative strength ranking of 97/100. Shares formed a cup with a 37% depth and have since driftAbcellera ...ALK Stock 12 Months Forecast. $51.25. (62.03% Upside) Based on 12 Wall Street analysts offering 12 month price targets for Alaska Air in the last 3 months. The average price target is $51.25 with a high forecast of $70.00 and a low forecast of $41.00. The average price target represents a 62.03% change from the last price of $31.63.2,065.00 -2.10(-0.10%) AbCellera Biologics Inc. (ABCL) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 4.7800 +0.0500 (+1.06%) At close: 04:00PM EST 4.7600 -0.02 (-0.42%)... Analyst Forecast. According to 7 analysts, the average rating for ABCL stock is "Strong Buy." The 12-month stock price forecast is $22.33, which is an …Previous Close $4.4. Volume 1.91M. Average Volume (3M) 1.64M. Market Cap. $1.28B. Enterprise Value $1.28B. Total Cash (Recent Filing) $795.69K. Total Debt (Recent Filing) $84.03K. Price to Earnings (P/E) -9.8.AbCellera Biologics (ABCL) is a biotech company that discovers antibodies from natural immune responses. The company has a consensus rating of Buy and a forecasted upside of 461.1% from its current price of $4.04. See the latest news, analysis, earnings, and insider trading of ABCL stock on MarketBeat.2,065.00 -2.10(-0.10%) AbCellera Biologics Inc. (ABCL) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 4.7800 +0.0500 (+1.06%) At close: 04:00PM EST 4.7600 -0.02 (-0.42%)...10 equities research analysts have issued twelve-month target prices for AbCellera Biologics' stock. Their ABCL share price …Previous Close $4.4. Volume 1.91M. Average Volume (3M) 1.64M. Market Cap. $1.28B. Enterprise Value $1.28B. Total Cash (Recent Filing) $795.69K. Total Debt (Recent Filing) $84.03K. Price to Earnings (P/E) -9.8.AbCellera Biologics Stock Chart and Share Price Forecast, Short-Term "ABCL" Stock Prediction for Next Days and Weeks Walletinvestor.com AbCellera Biologics Inc (ABCL) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024 WBA : 20.69 (-1.38%) MMM : 95.37 (+1.47%) ABC : 179.98 (-0.23%) Chart of the Day: AmerisourceBergen - Healthcare Giant Barchart - Fri Jul 7, 7:00AM CDT. The Chart of the Day belongs to the healthcare company AmerisourceBergen (ABC) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy ...

ABCL stock forecast for 2023 – 2027. Last updated: October 5, 2023. ABCL. AbCellera Biologics Inc. 4.43 D 1.14% (0.05) Are you interested in AbCellera Biologics Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the ABCL stock price in 2022-2027. Is ABCL a good long term stock? When should ...Given its relevancies, ABCL stock gained 13% of equity value in the trailing year. Still, ABCL surprisingly ranks among the most undervalued biotech stocks to buy. Currently, the market prices ...We’ve all flipped between different weather apps, wondering why each is giving a slightly different report. Before we look at AccuWeather, it’s important to understand the basics of weather forecasting. In the past, weather predictions were...ABCL Earnings Date and Information. AbCellera Biologics last issued its quarterly earnings data on November 2nd, 2023. The reported ($0.10) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.04. The business earned $6.60 million during the quarter, compared to the consensus estimate of $11.92 million.Instagram:https://instagram. 740i bmwmorgan stanley access investinghighest fixed rate annuitiesevolv technology stock You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading. cryptocurrency trading coursearbor realty trust dividend Nov 25, 2023 · At the close of trading, the stock’s price was $4.50, to imply an increase of 1.58% or $0.07 in intraday trading. The ABCL share’s 52-week high remains $14.15, putting it -214.44% down since that peak but still an impressive 14.0% since price per share fell to its 52-week low of $3.87. best crypto coin tracker Key points: Despite only being released into the Australian market a few months ago, Mounjaro is in short supply. It has been approved by the TGA as a diabetes treatment but is being prescribed ...The average twelve-month price prediction for AbCellera Biologics is $21.88 with a high price target of $34.00 and a low price target of $12.00. Learn more on ABCL's analyst rating history. Do Wall Street analysts like AbCellera Biologics more than its competitors?